Immunocore
United KingdomEntry
2021
Hold
5yr
Status
Active
Who owns Immunocore?
Immunocore is a British Biotech company, currently owned by Rosetta Capital since 2021 and General Atlantic.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Rosetta CapitalRosetta Capital V · 2021 · Secondaries
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
Rosetta CapitalActive
2021 · present(5yr) · Rosetta Capital V · 2021 · Secondaries
General AtlanticActive
2021 · present(5yr) · General Atlantic Portfolio · Buyout
More from Rosetta Capital V
Other portfolio companies in the same fund.
Ireland
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Immunocore?
Immunocore is currently owned by Rosetta Capital and General Atlantic, through Rosetta Capital V, since 2021.
When did Rosetta Capital and 1 other acquire Immunocore?
Rosetta Capital and 1 other acquired Immunocore in 2021.
Who has owned Immunocore over time?
Immunocore has been through 2 private-equity ownership periods: Rosetta Capital · via Rosetta Capital V · since 2021; General Atlantic · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue